|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
127,470,000 |
Market
Cap: |
1.89(B) |
Last
Volume: |
639,983 |
Avg
Vol: |
1,080,540 |
52
Week Range: |
$11.665 - $20.73 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
6,112 |
8,699 |
11,368 |
11,368 |
Total Sell Value |
$97,579 |
$136,292 |
$185,375 |
$185,375 |
Total People Sold |
1 |
2 |
2 |
2 |
Total Sell Transactions |
1 |
2 |
3 |
3 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Albitar Maher |
Chief Medical Officer |
|
2016-09-12 |
4 |
S |
$8.21 |
$418,710 |
D/D |
(51,000) |
105,300 |
|
- |
|
Albitar Maher |
Chief Medical Officer |
|
2016-09-09 |
4 |
S |
$8.31 |
$75,413 |
D/D |
(9,075) |
156,300 |
|
- |
|
Albitar Maher |
Chief Medical Officer |
|
2016-08-19 |
4 |
D |
$8.26 |
$286,003 |
D/D |
(34,625) |
228,867 |
|
- |
|
Albitar Maher |
Chief Medical Officer |
|
2016-08-19 |
4 |
S |
$8.23 |
$3,045,100 |
D/D |
(370,000) |
263,492 |
|
- |
|
Albitar Maher |
Chief Medical Officer |
|
2016-08-19 |
4 |
OE |
$1.43 |
$1,190,500 |
D/D |
570,000 |
633,492 |
|
- |
|
Van Oort Douglas M |
Chairman and CEO |
|
2016-05-27 |
4 |
S |
$8.74 |
$3,347,420 |
D/D |
(383,000) |
1,675,000 |
|
- |
|
Van Oort Douglas M |
Chairman and CEO |
|
2016-05-26 |
4 |
S |
$8.69 |
$854,983 |
D/D |
(98,387) |
2,058,000 |
|
- |
|
Van Oort Douglas M |
Chairman and CEO |
|
2016-05-25 |
4 |
D |
$8.65 |
$1,026,002 |
D/D |
(118,613) |
2,156,387 |
|
- |
|
Van Oort Douglas M |
Chairman and CEO |
|
2016-05-25 |
4 |
OE |
$1.71 |
$1,026,000 |
D/D |
600,000 |
2,275,000 |
|
- |
|
Ross Steven A |
CIO |
|
2016-05-18 |
4 |
S |
$8.50 |
$153,000 |
D/D |
(18,000) |
4,500 |
|
- |
|
Ross Steven A |
CIO |
|
2016-05-18 |
4 |
S |
$8.50 |
$153,000 |
D/D |
(18,000) |
4,500 |
|
- |
|
Ross Steven A |
CIO |
|
2016-05-18 |
4 |
OE |
$4.78 |
$86,040 |
D/D |
18,000 |
22,500 |
|
- |
|
Ross Steven A |
CIO |
|
2016-05-18 |
4 |
OE |
$4.78 |
$86,040 |
D/D |
18,000 |
22,500 |
|
- |
|
Robison William J |
Director |
|
2016-05-09 |
4 |
OE |
$4.78 |
$15,932 |
D/D |
3,333 |
177,196 |
|
- |
|
Ross Steven A |
CIO |
|
2016-05-09 |
4 |
S |
$8.22 |
$123,300 |
D/D |
(15,000) |
4,500 |
|
- |
|
Ross Steven A |
CIO |
|
2016-05-09 |
4 |
OE |
$4.78 |
$71,700 |
D/D |
15,000 |
19,500 |
|
- |
|
Jones Steven C |
Executive VP of Finance |
|
2016-05-03 |
4 |
GA |
$8.21 |
$164,200 |
I/I |
20,000 |
52,157 |
|
- |
|
Jones Steven C |
Executive VP of Finance |
|
2016-05-03 |
4 |
GD |
$8.21 |
$164,200 |
D/D |
20,000 |
266,251 |
|
- |
|
Jones Steven C |
Executive VP of Finance |
|
2016-05-02 |
4 |
S |
$8.21 |
$1,459,286 |
I/I |
(177,745) |
3,150,000 |
|
- |
|
Balliet Jennifer |
VP of Human Resources |
|
2016-04-29 |
4 |
OE |
$1.45 |
$4,834 |
D/D |
3,334 |
3,799 |
|
- |
|
Ross Steven A |
CIO |
|
2016-04-29 |
4 |
S |
$8.11 |
$912,375 |
D/D |
(112,500) |
4,500 |
|
- |
|
Ross Steven A |
CIO |
|
2016-04-29 |
4 |
OE |
$3.93 |
$442,125 |
D/D |
112,500 |
117,000 |
|
- |
|
Crowther Bruce K |
Director |
|
2016-04-20 |
4 |
A |
$7.15 |
$15,373 |
D/D |
2,150 |
12,130 |
|
- |
|
Hipp Raymond R |
Director |
|
2016-04-20 |
4 |
A |
$7.15 |
$15,373 |
D/D |
2,150 |
266,944 |
|
- |
|
Robison William J |
Director |
|
2016-04-20 |
4 |
A |
$7.15 |
$15,373 |
D/D |
2,150 |
173,863 |
|
- |
|
544 Records found
|
|
Page 16 of 22 |
|
|